Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Baldazzi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|June 28, 2023
In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast CancersManuela Santarosa, Davide Baldazzi, Michela Armellin, et al.
Nucleic Acids Research|May 8, 2021
BENZ WS: the Bologna ENZyme Web Server for four-level EC number annotationDavide Baldazzi, Castrense Savojardo, Pier Luigi Martelli, et al.
Biomedicines|August 6, 2020
Highlighting Human Enzymes Active in Different Metabolic Pathways and Diseases: The Case Study of EC 1.2.3.1 and EC 2.3.1.9Giulia Babbi, Davide Baldazzi, Castrense Savojardo, et al.
International Journal of Molecular Sciences|January 11, 2022
A Glance into MTHFR Deficiency at a Molecular LevelCastrense Savojardo, Giulia Babbi, Davide Baldazzi, et al.
Scientific Reports|October 26, 2022
Mapping human disease-associated enzymes into Reactome allows characterization of disease groups and their interactionsCastrense Savojardo, Davide Baldazzi, Giulia Babbi, et al.
Frontiers in Molecular Biosciences|October 3, 2022
Pathogenic variation types in human genes relate to diseases through Pfam and InterPro mappingGiulia Babbi, Castrense Savojardo, Davide Baldazzi, et al.
Frontiers in Genetics|December 5, 2024
<i>DElite</i>: a tool for integrated differential expression analysisDavide Baldazzi, Michele Doni, Beatrice Valenti, et al.
JCI Insight|October 13, 2020
Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumorsDaniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, et al.
NPJ Precision Oncology|January 20, 2026
KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GISTSimona Gloazzo, Marta Sbaraglia, Elena Bellan, et al.
Histopathology|July 31, 2023
Fusion transcriptome profiling defines the monoclonal origin of multifocal epithelioid haemangioma of boneCostantino Errani, Ilaria De Benedictis, Alberto Righi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|June 28, 2023
In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast CancersManuela Santarosa, Davide Baldazzi, Michela Armellin, et al.
Nucleic Acids Research|May 8, 2021
BENZ WS: the Bologna ENZyme Web Server for four-level EC number annotationDavide Baldazzi, Castrense Savojardo, Pier Luigi Martelli, et al.
Biomedicines|August 6, 2020
Highlighting Human Enzymes Active in Different Metabolic Pathways and Diseases: The Case Study of EC 1.2.3.1 and EC 2.3.1.9Giulia Babbi, Davide Baldazzi, Castrense Savojardo, et al.
International Journal of Molecular Sciences|January 11, 2022
A Glance into MTHFR Deficiency at a Molecular LevelCastrense Savojardo, Giulia Babbi, Davide Baldazzi, et al.
Scientific Reports|October 26, 2022
Mapping human disease-associated enzymes into Reactome allows characterization of disease groups and their interactionsCastrense Savojardo, Davide Baldazzi, Giulia Babbi, et al.
Frontiers in Molecular Biosciences|October 3, 2022
Pathogenic variation types in human genes relate to diseases through Pfam and InterPro mappingGiulia Babbi, Castrense Savojardo, Davide Baldazzi, et al.
Frontiers in Genetics|December 5, 2024
<i>DElite</i>: a tool for integrated differential expression analysisDavide Baldazzi, Michele Doni, Beatrice Valenti, et al.
JCI Insight|October 13, 2020
Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumorsDaniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, et al.
NPJ Precision Oncology|January 20, 2026
KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GISTSimona Gloazzo, Marta Sbaraglia, Elena Bellan, et al.
Histopathology|July 31, 2023
Fusion transcriptome profiling defines the monoclonal origin of multifocal epithelioid haemangioma of boneCostantino Errani, Ilaria De Benedictis, Alberto Righi, et al.
Pageof 2